Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.82 USD | +0.68% |
|
+15.45% | +4.63% |
06-24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
06-13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.63% | 542M | |
+38.36% | 52.73B | |
+38.20% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Piper Sandler Initiates Coverage of Replimune Group With Overweight Rating